ArticleCytotherapy2022

Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019.

Stacey-Ann Whittaker Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.